JPWO2023182342A5 - - Google Patents

Info

Publication number
JPWO2023182342A5
JPWO2023182342A5 JP2024509154A JP2024509154A JPWO2023182342A5 JP WO2023182342 A5 JPWO2023182342 A5 JP WO2023182342A5 JP 2024509154 A JP2024509154 A JP 2024509154A JP 2024509154 A JP2024509154 A JP 2024509154A JP WO2023182342 A5 JPWO2023182342 A5 JP WO2023182342A5
Authority
JP
Japan
Prior art keywords
skeletal muscle
pharmaceutically acceptable
acceptable salt
intramuscular administration
atrophy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024509154A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2023182342A1 (cg-RX-API-DMAC7.html
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2023/011182 external-priority patent/WO2023182342A1/ja
Publication of JPWO2023182342A1 publication Critical patent/JPWO2023182342A1/ja
Publication of JPWO2023182342A5 publication Critical patent/JPWO2023182342A5/ja
Pending legal-status Critical Current

Links

JP2024509154A 2022-03-22 2023-03-22 Pending JPWO2023182342A1 (cg-RX-API-DMAC7.html)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2022045904 2022-03-22
PCT/JP2023/011182 WO2023182342A1 (ja) 2022-03-22 2023-03-22 骨格筋増強剤

Publications (2)

Publication Number Publication Date
JPWO2023182342A1 JPWO2023182342A1 (cg-RX-API-DMAC7.html) 2023-09-28
JPWO2023182342A5 true JPWO2023182342A5 (cg-RX-API-DMAC7.html) 2026-03-30

Family

ID=88101118

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024509154A Pending JPWO2023182342A1 (cg-RX-API-DMAC7.html) 2022-03-22 2023-03-22

Country Status (4)

Country Link
US (1) US20250228796A1 (cg-RX-API-DMAC7.html)
EP (1) EP4497435A4 (cg-RX-API-DMAC7.html)
JP (1) JPWO2023182342A1 (cg-RX-API-DMAC7.html)
WO (1) WO2023182342A1 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2025070707A1 (cg-RX-API-DMAC7.html) * 2023-09-29 2025-04-03

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5998015A (ja) * 1982-11-27 1984-06-06 Microbial Chem Res Found 免疫賦活剤
EP1075254A2 (en) * 1998-04-03 2001-02-14 Theodore Toney Ilenchuk The use of polyamines in the treatment of dermatological symptoms
US9144601B2 (en) 2011-09-15 2015-09-29 Seikagaku Corporation Skeletal muscle regeneration promoter
CA3086250A1 (en) * 2017-12-20 2019-06-27 Societe Des Produits Nestle S.A. Compositions and methods using a combination of autophagy inducer and high protein for induction of autophagy
JP7742026B2 (ja) * 2020-04-03 2025-09-19 三菱瓦斯化学株式会社 筋肉増強剤

Similar Documents

Publication Publication Date Title
JP2024516371A5 (cg-RX-API-DMAC7.html)
JP2022116028A (ja) 前立腺がんの内部放射線療法のための前立腺特異的膜抗原を標的とした高親和性薬剤
CN105849105B (zh) 制备流感病毒复制抑制剂的方法
JP2022068329A5 (cg-RX-API-DMAC7.html)
IL273169B2 (en) New combination of active agents for the treatment of progressive fibrosing interstitial lung diseases (pf-ild)
JP2018502898A5 (cg-RX-API-DMAC7.html)
JP2019503365A5 (cg-RX-API-DMAC7.html)
JP2022502500A5 (cg-RX-API-DMAC7.html)
JP2016534063A5 (cg-RX-API-DMAC7.html)
JP2023166406A5 (cg-RX-API-DMAC7.html)
JP2022522819A5 (cg-RX-API-DMAC7.html)
JP2022515293A5 (cg-RX-API-DMAC7.html)
CN116134028A (zh) 一种具有降解btk激酶的化合物及其制备方法和药学上的应用
JP2017222722A5 (cg-RX-API-DMAC7.html)
JP2012521355A5 (cg-RX-API-DMAC7.html)
JP2022552187A5 (cg-RX-API-DMAC7.html)
JP2017522304A5 (cg-RX-API-DMAC7.html)
JP2016507500A5 (cg-RX-API-DMAC7.html)
JP2018145180A5 (cg-RX-API-DMAC7.html)
JP2022514537A5 (cg-RX-API-DMAC7.html)
JP2019085364A5 (cg-RX-API-DMAC7.html)
IL272834B2 (en) Amantadine compositions, preparations thereof, and methods of use
JP2020527138A5 (cg-RX-API-DMAC7.html)
JP2024543479A5 (cg-RX-API-DMAC7.html)
JP7752870B2 (ja) 発毛を誘導するためのイタコネートおよびその誘導体/類似体の使用